Medical/Pharmaceuticals
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM
SHANGHAI and HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
2021-01-28 08:00
2761
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM
SHANGHAI and HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
2021-01-28 08:00
4918
Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair
HERZLIYA, Israel, Jan. 28, 2021 /PRNewswire/ -- Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring. The transseptal AMEND ...
2021-01-28 02:04
2731
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study
SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical compa...
2021-01-27 20:00
4688
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
SEOUL, South Korea, Jan. 27, 2021 /PRNewswire/ -- Lunit, a South Korean medical
AI software company, announced a partnership with a leading PACS provider
INFINITT Healthcare to accelerate its global expansion.
2021-01-27 15:37
1992
Casio to Release DERMOCAMERA™, Allowing Dermatologists to Capture Close-up and Ordinary Shots of Affected Areas Using a Single Device
TOKYO, Jan. 27, 2021 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera. The new product was created based on collaborativ...
2021-01-27 12:21
2324
Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation
HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce its innovation Xuanzhu Biopharma...
2021-01-27 11:21
6834
Kingston x CSD Reveals APAC Top 10 heartwarming face mask designs
* Over 3,100 entries received across all APAC regions for Kingston x CSD APAC Mask Design Competition as artists induce positivity through mask designs, share compelling life stories and reflections on 2020 * Vote online now for the favourite finalist and decide who the winner will be TAIPEI, ...
2021-01-27 10:00
2641
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta
MONTREAL, Jan. 26, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global
provider of specialized precision medicine laboratory services to the
biopharmaceutical industry, is pleased to announce its new corporate name,
CellCarta, and brand identity.
2021-01-26 21:23
4208
Connect Biopharma Strengthens Leadership Team with Key Hire
New Chief Business Officer joins company as part of organizational growth strategy SAN DIEGO and TAICANG, SUZHOU, China, Jan. 26, 2021 /PRNewswire/ -- Connect Biopharma, a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory disea...
2021-01-26 21:00
1626
Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors
SHENZHEN, China, Jan. 26, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, today launched its new VS 9 and VS 8 Vital Signs Monitors, which are now available inEurope, Australia and other selected regions. From inpatient admissio...
2021-01-26 19:29
6000
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program
VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021. BioVaxys is ple...
2021-01-25 21:00
3087
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
- BAVENCIO maintenance treatment significantly extended median overall survival versus standard of care in the Phase III JAVELIN Bladder 100 study - First and only immunotherapy to demonstrate a significant overall survival benefit in the first-line setting in a Phase III trial - BAVENCIO firs...
2021-01-25 15:00
4258
Boehringer Ingelheim named Top Employer in Malaysia, across Southeast Asia, and South Korea for 2021
KUALA LUMPUR, Malaysia, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inMalaysia and six other countries acrossAsia - Indonesia, Philippines, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on exce...
2021-01-25 10:00
2100
Boehringer Ingelheim named Top Employer in Vietnam, across Southeast Asia, and South Korea for 2021
HO CHI MINH CITY, Vietnam, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inVietnam and six other countries acrossAsia - Indonesia, Malaysia, Philippines, Singapore, South Korea andThailand - by Top Employers Institute, the global authority on ex...
2021-01-25 10:00
2254
Boehringer Ingelheim named Top Employer in Philippines, across Southeast Asia, and South Korea for 2021
MAKATI CITY, Philippines, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inPhilippines and six other countries acrossAsia - Indonesia, Malaysia, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on ex...
2021-01-25 10:00
1987
Boehringer Ingelheim named Top Employer in Singapore, across Southeast Asia, and South Korea for 2021
SINGAPORE, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inSingapore and six other countries across Asia - Indonesia, Malaysia, Philippines, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on excellence in peo...
2021-01-25 10:00
2371
Boehringer Ingelheim named Top Employer in Thailand, across Southeast Asia, and South Korea for 2021
BANGKOK, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inThailand and six other countries across Asia - Indonesia, Malaysia, Philippines, Singapore, South Korea and Vietnam - by Top Employers Institute, the global authority on excellence in peop...
2021-01-25 10:00
1917
Boehringer Ingelheim named Top Employer in Indonesia, across Southeast Asia, and South Korea for 2021
JAKARTA, Indonesia, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inIndonesia and six other countries across Asia - Malaysia, Philippines, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on excellen...
2021-01-25 10:00
2058
Antengene Announces Approval of IND Application in China for ATG-010 (Selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study
SHANGHAI and HONG KONG, Jan. 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
2021-01-25 08:20
2720
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 295 media titles]
2024-11-28 17:24TAILG's First Flagship Store in Indonesia Grandly Opens
[Picked up by 283 media titles]
2024-11-22 21:59
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
11862
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
7915
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
7659
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7071
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5407